Effect of ipragliflozin, a sodium-glucose co-transporter 2 inhibitor, on diuresis and neurohormonal activation in type 2 diabetes mellitus and heart failure
Event:
ESC Congress 2016
Topic:
Pharmacologic therapy
Session:
Novel pharmacological therapy in chronic heart failure
